drugset / Trial / NCT00815659
Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The primary objective is to evaluate the efficacy of rosuvastatin therapy on plasma lipid profile (Low Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), total cholesterol, triglyceride) in patients with metabolic syndrome.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | — |